New preprint online today!
Patient Benefit and Risk in Anticancer Drug Development: A Systematic Review of the Ixabepilone Trial Portfolio by Carlisle et al, medRxiv, 2019.
And here's a blog post, explaining why this is a preprint and why we didn't publish this in a journal:
The social network of the future: No ads, no corporate surveillance, ethical design, and decentralization! Own your data with Mastodon!